Aspire Biopharma Holdings, Inc. (ASBP) vs Curis, Inc. (CRIS)
A side-by-side comparison of Aspire Biopharma Holdings, Inc. and Curis, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ASBP
Aspire Biopharma Holdings, Inc.
$8.77HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
CRIS
Curis, Inc.
$0.77HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
Total return — ASBP vs CRIS
growth of $100 · dividends reinvested · last 4yASBP -99.9% (-83.5%/yr)CRIS -99.9% (-81.3%/yr)CRIS compounded faster over this window
ASBP CRIS
ASBP vs CRIS: by the numbers
- •CRIS is the larger company ($2M vs $1M market cap).
- •Both run net losses; CRIS's is the smaller (-490.33% vs -11314.24% net margin).
Metrics side by side
Valuation
| Metric | ASBP | CRIS |
|---|---|---|
| P/S ratio | 10.36 | 0.35 |
| P/B ratio | 0.09 | 0.32 |
Profitability
| Metric | ASBP | CRIS |
|---|---|---|
| Gross margin | -1.87% | 99.28% |
| Operating margin | -312016.95% | -348.43% |
| Net margin | -11314.24% | -490.33% |
| ROE | -93.97% | -450.54% |
| ROIC | -59.81% | -567.17% |
Growth (annualized)
| Metric | ASBP | CRIS |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -15.88% |
| Total return CAGR (5Y) | N/A | -81.06% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.